Related Experiment Video
Updated: Aug 7, 2026
11:32
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Optimal therapy for severe pneumococcal community-acquired pneumonia
Manel Luján1, Miguel Gallego, Jordi Rello
1Pulmonary Service, Corporació Parc Taulí/Institut Universitari Parc Taulí, Sabadell, Spain.
Intensive Care Medicine
|June 23, 2006
Summary
Streptococcus pneumoniae causes most community-acquired pneumonia (CAP) ICU admissions and deaths. Optimal antibiotic regimens, especially for severe cases, require further study to improve patient survival.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Pulmonology
Background:
- Streptococcus pneumoniae is a primary cause of community-acquired pneumonia (CAP), leading to significant ICU admissions and mortality.
- Patient outcomes are influenced by a complex interplay of host factors, bacterial virulence, and therapeutic interventions.
Purpose of the Study:
- To review the factors influencing outcomes in Streptococcus pneumoniae CAP.
- To evaluate current antibiotic treatment strategies and identify areas for improvement, particularly in severe cases.
Main Methods:
- Literature review of studies on Streptococcus pneumoniae CAP, focusing on mortality, risk factors, and treatment efficacy.
- Analysis of antibiotic susceptibility data and clinical trial findings.
Main Results:
- While most S. pneumoniae isolates remain susceptible to standard antibiotics like cefotaxime, ceftriaxone, and amoxicillin, discordant initial therapy is linked to excess mortality.
- Emerging evidence suggests combination therapy, potentially involving macrolides, may improve survival in bacteremic patients with severe CAP.
Conclusions:
- Further prospective, randomized clinical trials are needed to establish optimal antibiotic regimens for high-severity pneumonia patients (Pneumonia Severity Index > 90).
- Understanding host-pathogen interactions and modifiable factors is crucial for reducing CAP-related deaths.
Related Concept Videos
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...